Used primarily as a key intermediate in pharmaceutical synthesis, especially in Suzuki-Miyaura cross-coupling reactions to construct biaryl frameworks found in active pharmaceutical ingredients. Its boronate ester group enables efficient carbon-carbon bond formation under mild conditions, making it valuable in the development of drug candidates targeting central nervous system disorders and oncology. The cyclopropylmethoxy moiety contributes to metabolic stability and improved pharmacokinetic profiles in final drug molecules. Commonly employed in late-stage functionalization due to its compatibility with diverse reaction conditions and functional groups.